Why the study?
Does bone marrow-derived stem cell transplantation improve contractility and capillary density in a rabbit model of doxorubicin-induced heart failure?
Population
Rabbit model of doxorubicin-induced heart failure, n=41.
Comparison
Bone marrow-derived stem cell transplantation… vs Sham treatment or no therapy.
Design
Preclinical
Follow-up
4 weeks
Authors
Loading...
Hypothesis-generating for BMC therapy in doxorubicin cardiomyopathy; leaves open human translation pending clinical trials.
Does bone marrow-derived stem cell transplantation improve contractility and capillary density in a rabbit model of doxorubicin-induced heart failure?
In a rabbit model of doxorubicin-induced cardiomyopathy, local transplantation of autologous bone marrow-derived stem cells improved global contractility and capillary density without transdifferentiating into cardiomyocytes.
Garbade et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: